title: Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.
authors.affiliation: Oncohematology Division, IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, and Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
authors.forename: Alessandra
authors.identifier: http://orcid.org/0000-0001-7958-4966
authors.initials: A
authors.lastname: Iurlo
authors.affiliation: Division of Pathology, Department of Pathophysiology and Transplantation, University of Milan, and IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, Milan, Italy.
authors.forename: Umberto
authors.initials: U
authors.lastname: Gianelli
authors.affiliation: Oncohematology Division, IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, and Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
authors.forename: Daniele
authors.initials: D
authors.lastname: Cattaneo
authors.affiliation: Institute of Pathology, University of Cologne, Cologne, Germany.
authors.forename: Juergen
authors.initials: J
authors.lastname: Thiele
authors.affiliation: Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York.
authors.forename: Attilio
authors.initials: A
authors.lastname: Orazi
mesh_terms: D019337:Hematologic Neoplasms / Q000145:classification / Q000175:diagnosis / Q000235:genetics; D006801:Humans; D009196:Myeloproliferative Disorders / Q000145:classification / Q000175:diagnosis / Q000235:genetics; D017410:Practice Guidelines as Topic; D014944:World Health Organization